Steris (STE) has disclosed a new risk, in the Corporate Activity and Growth category.
Steris, during the quarter ending December 31, 2024, did not see any of its directors or officers engage in any changes to trading arrangements, as per Rule 10b5-1 or non-Rule 10b5-1, according to Item 408 of Regulation S-K. This lack of trading activity might suggest stability or a lack of strategic financial movements by the company’s insiders. Such a situation could imply that the company is maintaining its current course without significant changes in its financial risk posture. However, it may also indicate a missed opportunity for strategic insider trading to hedge against potential future risks.
The average STE stock price target is $265.00, implying 18.71% upside potential.
To learn more about Steris’ risk factors, click here.